Global Tissue Heart Valves Market 2016-2020

Table of Content

PART 01: Executive summary

• Highlights

PART 02: Scope of the report

• Market overview
• Top-vendor offerings

PART 03: Market research methodology

• Research methodology
• Economic indicators

PART 04: Introduction

• Key market highlights

PART 05: Market landscape

• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Cost analysis

• Cost analysis of valve replacement procedures

PART 07: Market segmentation by product

PART 08: Geographical segmentation

• Tissue heart valves market in Americas
• Tissue heart valves market in EMEA
• Tissue heart valves market in APAC

PART 09: Market drivers

• Prevalence of heart valve diseases
• Demand for stentless tissue valves
• Implementation of MI procedures
• Rise in geriatric population

PART 10: Impact of drivers

PART 11: Market challenges

• Use of alternative products
• Risk of potential complications
• Lack of skilled personnel
• Stringent regulatory framework

PART 12: Impact of drivers and challenges

PART 13: Market trends

• Demand for tissue heart valves in APAC
• Preference among geriatric population
• Increase in M&A

PART 14: Vendor landscape

• Competitive scenario
• Market share analysis 2015
• Edwards Lifesciences
• LivaNova
• Medtronic
• St. Jude Medical
• Other prominent vendors

PART 15: Appendix

• List of abbreviations

• PART 16: Explore Technavio